1     
EPINEPHRINE AUTO-INJECTOR USE EXPANSION

2     
2015 GENERAL SESSION

3     
STATE OF UTAH

4     
Chief Sponsor: Margaret Dayton

5     
House Sponsor: Patrice M. Arent

6     

7     LONG TITLE
8     General Description:
9          This bill amends the Emergency Injection For Anaphylactic Reaction Act in the Utah
10     Health Code.
11     Highlighted Provisions:
12          This bill:
13          ▸     defines terms;
14          ▸     permits certain qualified entities to obtain a prescription for a supply of epinephrine
15     auto-injectors for use by a trained, qualified adult;
16          ▸     requires the qualified entity to store the supply of epinephrine auto-injectors in
17     accordance with standards developed by the Department of Health;
18          ▸      expands liability protection with respect to an anaphylactic reaction to:
19               •     a medical professional prescribing a supply of epinephrine auto-injectors;
20               •     a person conducting training; and
21               •     a qualified entity; and
22          ▸     provides administrative rulemaking authority to the Department of Health.
23     Money Appropriated in this Bill:
24          None
25     Other Special Clauses:
26          None
27     Utah Code Sections Affected:
28     AMENDS:
29          26-41-102, as last amended by Laws of Utah 2008, Chapter 64

30          26-41-103, as last amended by Laws of Utah 2008, Chapter 64
31          26-41-104, as last amended by Laws of Utah 2011, Chapter 297
32          26-41-105, as last amended by Laws of Utah 2008, Chapter 64
33          26-41-106, as last amended by Laws of Utah 2008, Chapter 64
34     ENACTS:
35          26-41-107, Utah Code Annotated 1953
36     

37     Be it enacted by the Legislature of the state of Utah:
38          Section 1. Section 26-41-102 is amended to read:
39          26-41-102. Definitions.
40          As used in this chapter:
41          (1) "Anaphylaxis" means a potentially life-threatening hypersensitivity to a substance.
42          (a) Symptoms of anaphylaxis may include shortness of breath, wheezing, difficulty
43     breathing, difficulty talking or swallowing, hives, itching, swelling, shock, or asthma.
44          (b) Causes of anaphylaxis may include insect sting, food allergy, drug reaction, and
45     exercise.
46          (2) "Epinephrine auto-injector" means a disposable drug delivery system with a
47     spring-activated concealed needle that is designed for emergency administration of epinephrine
48     to provide rapid, convenient first-aid for persons suffering a potentially fatal anaphylactic
49     reaction.
50          (3) "Qualified adult" means a person who:
51          (a) is 18 years of age or older; and
52          (b) has successfully completed the training program established in Section 26-41-104.
53          (4) "Qualified entity":
54          (a) means a facility or organization that employs, contracts with, or has a similar
55     relationship with a qualified adult who is likely to have contact with another person who may
56     experience anaphylaxis; and
57          (b) includes:

58          (i) recreation camps;
59          (ii) an education facility, school, or university;
60          (iii) a day care facility;
61          (iv) youth sports leagues;
62          (v) amusement parks;
63          (vi) food establishments;
64          (vii) places of employment; and
65          (viii) recreation areas.
66          Section 2. Section 26-41-103 is amended to read:
67          26-41-103. Voluntary participation.
68          (1) This chapter does not create a duty or standard of care for:
69          (a) a person to be trained in the use and storage of epinephrine auto-injectors[.]; or
70          (b) except as provided in Subsection (5), a qualified entity to store epinephrine
71     auto-injectors on its premises.
72          (2) Except as provided in Subsections (3) and (5), a decision by a person to
73     successfully complete a training program under Section 26-41-104 and to make emergency
74     epinephrine auto-injectors available under the provisions of this chapter is voluntary.
75          (3) A school, school board, or school official may not prohibit or dissuade a teacher or
76     other school employee at a primary or secondary school in the state, either public or private,
77     from:
78          (a) completing a training program under Section 26-41-104;
79          (b) possessing or storing an epinephrine auto-injector on school property if:
80          (i) the teacher or school employee is a qualified adult; and
81          (ii) the possession and storage is in accordance with the training received under Section
82     26-41-104; or
83          (c) administering an epinephrine auto-injector to any person, if:
84          (i) the teacher or school employee is a qualified adult; and
85          (ii) the administration is in accordance with the training received under Section

86     26-41-104.
87          (4) A school, school board, or school official may encourage a teacher or other school
88     employee to volunteer to become a qualified adult.
89          (5) (a) Each primary or secondary school in the state, both public and private, shall
90     make an emergency epinephrine auto-injector available to any teacher or other school
91     employee who:
92          (i) is employed at the school; and
93          (ii) is a qualified adult.
94          (b) This section does not require a school described in Subsection (5)(a) to keep more
95     than one emergency epinephrine auto-injector on the school premises, so long as it may be
96     quickly accessed by a teacher or other school employee, who is a qualified adult, in the event of
97     an emergency.
98          (6) No school, school board, or school official shall retaliate or otherwise take adverse
99     action against a teacher or other school employee for:
100          (a) volunteering under Subsection (2);
101          (b) engaging in conduct described in Subsection (3); or
102          (c) failing or refusing to become a qualified adult.
103          Section 3. Section 26-41-104 is amended to read:
104          26-41-104. Training in use and storage of epinephrine auto-injector.
105          (1) (a) Each primary and secondary school in the state, both public and private, shall
106     make initial and annual refresher training, regarding the storage and emergency use of an
107     epinephrine auto-injector, available to any teacher or other school employee who volunteers to
108     become a qualified adult.
109          (b) The training described in Subsection (1)(a) may be provided by the school nurse, or
110     other person qualified to provide such training, designated by the school district physician, the
111     medical director of the local health department, or the local emergency medical services
112     director.
113          (2) A person who provides training under Subsection (1) or (6) shall include in the

114     training:
115          (a) techniques for recognizing symptoms of anaphylaxis;
116          (b) standards and procedures for the storage and emergency use of epinephrine
117     auto-injectors;
118          (c) emergency follow-up procedures, including calling the emergency 911 number and
119     contacting, if possible, the student's parent and physician; and
120          (d) written materials covering the information required under this Subsection (2).
121          (3) A qualified adult shall retain for reference the written materials prepared in
122     accordance with Subsection (2)(d).
123          (4) A public school shall permit a student to possess an epinephrine auto-injector or
124     possess and self-administer an epinephrine auto-injector if:
125          (a) the student's parent or guardian signs a statement:
126          (i) authorizing the student to possess or possess and self-administer an epinephrine
127     auto-injector; and
128          (ii) acknowledging that the student is responsible for, and capable of, possessing or
129     possessing and self-administering an epinephrine auto-injector; and
130          (b) the student's health care provider provides a written statement that states that:
131          (i) it is medically appropriate for the student to possess or possess and self-administer
132     an epinephrine auto-injector; and
133          (ii) the student should be in possession of the epinephrine auto-injector at all times.
134          (5) The Utah Department of Health, in cooperation with the state superintendent of
135     public instruction, shall design forms to be used by public schools for the parental and health
136     care providers statements described in Subsection [(6)] (4).
137          (6) (a) The department:
138          (i) shall approve educational programs conducted by other persons, to train:
139          (A) people under Subsection (6)(b) of this section, regarding the proper use and storage
140     of emergency epinephrine auto-injectors; and
141          (B) a qualified entity regarding the proper storage and emergency use of epinephrine

142     auto-injectors; and
143          (ii) may, as funding is available, conduct educational programs to train people
144     regarding the use of and storage of emergency epinephrine auto-injectors.
145          (b) A person who volunteers to receive training as a qualified adult to administer an
146     epinephrine auto-injector under the provisions of this Subsection (6) shall demonstrate a need
147     for the training to the department, which may be based upon occupational, volunteer, or family
148     circumstances, and shall include:
149          (i) camp counselors;
150          (ii) scout leaders;
151          (iii) forest rangers;
152          (iv) tour guides; and
153          (v) other persons who have or reasonably expect to have [responsibility for] contact
154     with at least one other person as a result of the person's occupational or volunteer status.
155          [(7) The department shall adopt rules in accordance with Title 63G, Chapter 3, Utah
156     Administrative Rulemaking Act, to:]
157          [(a) establish and approve training programs in accordance with this section; and]
158          [(b) establish a procedure for determining the need for training under Subsection
159     (6)(b)(v).]
160          Section 4. Section 26-41-105 is amended to read:
161          26-41-105. Authority to obtain and use an epinephrine auto-injector.
162          (1) A qualified adult who is a teacher or other school employee at a public or private
163     primary or secondary school in the state, or a school nurse, may obtain from the school district
164     physician, the medical director of the local health department, or the local emergency medical
165     services director a prescription for epinephrine auto-injectors.
166          (2) A qualified adult may obtain from a physician, pharmacist, or any other person or
167     entity authorized to prescribe or [sell prescribed medicines or] dispense prescription drugs, a
168     prescription for an epinephrine auto-injector.
169          (3) A qualified adult:

170          (a) may immediately administer an epinephrine auto-injector to a person exhibiting
171     potentially life-threatening symptoms of anaphylaxis when a physician is not immediately
172     available; and
173          (b) shall initiate emergency medical services or other appropriate medical follow-up in
174     accordance with the training materials retained under Section 26-41-104 after administering an
175     epinephrine auto-injector.
176          (4) (a) A qualified entity that complies with Subsection (4)(b), may obtain from a
177     physician, pharmacist, or any other person or entity authorized to prescribe or dispense
178     prescription drugs, a prescription for a supply of epinephrine auto-injectors, for:
179          (i) storing the epinephrine auto-injectors on the qualified entity's premises; and
180          (ii) use by a qualified adult in accordance with Subsection (3).
181          (b) A qualified entity shall:
182          (i) designate an individual to complete an initial and annual refresher training program
183     regarding the proper storage and emergency use of an epinephrine auto-injector available to a
184     qualified adult; and
185          (ii) store epinephrine auto-injectors in accordance with the standards established by the
186     department in Section 26-41-107.
187          Section 5. Section 26-41-106 is amended to read:
188          26-41-106. Immunity from liability.
189          (1) [A qualified adult who acts in good faith is] The following, if acting in good faith,
190     are not liable in any civil or criminal action for any act taken or not taken under the authority of
191     this chapter with respect to an anaphylactic reaction[.]:
192          (a) a qualified adult;
193          (b) a physician, pharmacist, or any other person or entity authorized to prescribe or
194     dispense prescription drugs;
195          (c) a person who conducts training described in Section 26-41-104; and
196          (d) a qualified entity.
197          (2) Section 53A-11-601 does not apply to the administration of an epinephrine

198     auto-injector in accordance with this chapter.
199          (3) This section does not eliminate, limit, or reduce any other immunity from liability
200     or defense against liability that may be available under state law.
201          Section 6. Section 26-41-107 is enacted to read:
202          26-41-107. Administrative rulemaking authority.
203          The department shall adopt rules in accordance with Title 63G, Chapter 3, Utah
204     Administrative Rulemaking Act, to:
205          (1) establish and approve training programs in accordance with Section 26-41-104;
206          (2) establish a procedure for determining who is eligible for training as a qualified
207     adult under Subsection 26-41-104(6)(b)(v); and
208          (3) establish standards for storage of emergency auto-injectors by a qualified entity
209     under Section 26-41-104.